Cited by 362Cell death mechanisms and regulationNF-κB Signaling PathwaysImmune Response and Inflammation

TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation

Open access
Jouan-Lanhouet, S, Arshad, M I, Piquet-Pellorce, C, Martin-Chouly, C, Le Moigne-Muller, G, Van Herreweghe, F, Takahashi, N, Sergent, O +4 more·2012·Cell Death & Differentiation

Abstract

Although TRAIL (tumor necrosis factor (TNF)-related apoptosis inducing ligand) is a well-known apoptosis inducer, we have previously demonstrated that acidic extracellular pH (pHe) switches TRAIL-induced apoptosis to regulated necrosis (or necroptosis) in human HT29 colon and HepG2 liver cancer cells. Here, we investigated the role of RIPK1 (receptor interacting protein kinase 1), RIPK3 and PARP-1 (poly (ADP-ribose) polymerase-1) in TRAIL-induced necroptosis in vitro and in concanavalin A (Con A)-induced murine hepatitis. Pretreatment of HT29 or HepG2 with pharmacological inhibitors of RIPK1 or PARP-1 (Nec-1 or PJ-34, respectively), or transient transfection with siRNAs against RIPK1 or RIPK3, inhibited both TRAIL-induced necroptosis and PARP-1-dependent intracellular ATP depletion demonstrating that RIPK1 and RIPK3 were involved upstream of PARP-1 activation and ATP depletion. In the mouse model of Con A-induced hepatitis, where death of mouse hepatocytes is dependent on TRAIL and NKT (Natural Killer T) cells, PARP-1 activity was positively correlated with liver injury and hepatitis was prevented both by Nec-1 or PJ-34. These data provide new insights into TRAIL-induced necroptosis with PARP-1 being active effector downstream of RIPK1/RIPK3 initiators and suggest that pharmacological inhibitors of RIPKs and PARP-1 could be new treatment options for immune-mediated hepatitis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/cdd.2012.90

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Upon induction of necroptosis by TRAIL or β-lapachone, activated RIPK1 and RIPK3 appear to stimulate PARP1 enzymatic activity and promote ATP depletion and/or AIF release.

    “upon induction of necroptosis by TRAIL or β lapachone (an ortho naphthoquinone with antineoplastic activity) [683], activated RIPK1 and RIPK3 appear to stimulate the enzymatic activity of PARP1 and hence promote ATP depletion and/or AIF release [684, 685].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Jouan-Lanhouet, S., Arshad, M. I., Piquet-Pellorce, C., Martin-Chouly, C., Le Moigne-Muller, G., Van Herreweghe, F., Takahashi, N., Sergent, O., Lagadic-Gossmann, D., Vandenabeele, P., Samson, M., & Dimanche-Boitrel, M.-T.
Affiliations
  • Institut de Recherche en Santé, Environnement et Travail (FR)
  • Inserm (FR)
  • Ghent University (BE)
Venue
Cell Death & Differentiation
Published
2012-07-20
Volume
19
Issue
12
Pages
2003-2014
ISSN
  • 1350-9047 (ISSN-L)
  • 1476-5403
OpenAlex
W2086665516
Cited by
357
References
40
Citations by year
2026: 11 · 2025: 17 · 2024: 28 · 2023: 22 · 2022: 22 · 2021: 29 · 2020: 18 · 2019: 22 · 2018: 26 · 2017: 29 · 2016: 41 · 2015: 30 · 2014: 37 · 2013: 22 · 2012: 3
FWCI
11.82
Type
journal article
Language
en
Open access
Locations
  • Cell Death and Differentiation (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
  • Ghent University Academic Bibliography (Ghent University) (submittedVersion)
Funders
  • Association pour la Recherche sur le Cancer
  • European Commission (200767)
  • Institut National de la Santé et de la Recherche Médicale
  • Fonds Wetenschappelijk Onderzoek (G.0875.11, FWO G.0973.11, G.0973.11, FWO G.0875.11)
  • Universiteit Gent (01M00709)
  • Vlaams Instituut voor Biotechnologie (BOF09/01M00709)
  • Région Bretagne
  • Vlaamse regering (BOF09/01M00709)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
Keywords
TRAIL, necroptosis, RIPK1, RIPK3, PARP1, regulated necrosis, intracellular ATP depletion, Nec-1, PJ34, concanavalin A-induced hepatitis, NKT cells, hepatocyte death, colon cancer cells, liver cancer cells
MeSH terms
Poly(ADP-ribose) Polymerase Inhibitors, Adenosine Triphosphate, Animals, Cell Line, Disease Models, Animal, Humans, Hydrogen-Ion Concentration, Imidazoles, Indoles, Killer Cells, Natural, Phenanthrenes, Poly(ADP-ribose) Polymerases, Apoptosis, Reactive Oxygen Species, HT29 Cells, Hepatocytes, RNA Interference, RNA, Small Interfering, Mice, TNF-Related Apoptosis-Inducing Ligand, Receptor-Interacting Protein Serine-Threonine Kinases, Hep G2 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review